Skip to main content
Year archive

Valbiotis — 2025 filings

All 76 regulatory filings released by Valbiotis (ALVAL) in 2025, sourced directly from the official regulator.

76 Filings
2025 Period
2025 filings (76)
Filing Released Lang
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2025-12-19 French
VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance
Regulatory Filings
2025-12-18 English
VALBIOTIS SA: Valbiotis distingué par le prix Top Santé 2025 pour Valbiotis Plus® Sérénité, solution innovante pour l’équilibre émotionnel
Regulatory Filings
2025-12-18 French
VALBIOTIS SA: Valbiotis recognized by the 2025 Top Sante Award for Valbiotis Plus Serenity, an innovative solution for emotional balance
Regulatory Filings
2025-12-18 English
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
Regulatory Filings
2025-12-08 English
VALBIOTIS SA: Valbiotis annonce la fin du recrutement de l’étude clinique Cardio-Liver conduite avec TOTUM-448 pour les maladies métaboliques du foie (MASLD)
Regulatory Filings
2025-12-08 French
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM448 for metabolic liver diseases (MASLD)
Regulatory Filings
2025-12-08 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2025-11-25 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-11-25 French
Correction of a release from 17.11.2025 17:40 CET/CEST - VALBIOTIS SA: Valbiotis announces a major strategic agreement in Asia
M&A Activity
2025-11-17 English
VALBIOTIS SA: Valbiotis annonce un accord stratégique majeur en Asie
Regulatory Filings
2025-11-17 French
VALBIOTIS SA: Valbiotis announces a major strategic agreement in Asia
Regulatory Filings
2025-11-17 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-10-13 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-10-13 French
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap
Earnings Release H1 2025
2025-10-09 English
VALBIOTIS SA: Valbiotis publie ses comptes semestriels et confirme sa feuille de route
Interim / Quarterly Report H1 2025
2025-10-09 French
VALBIOTIS SA: Valbiotis publishes its interim financial statements and confirms its roadmap
Earnings Release H1 2025
2025-10-09 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2025-09-01 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-09-01 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2025-08-11 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-08-11 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Share Issue/Capital Change
2025-07-03 French
VALBIOTIS SA: Bilan semestriel du contrat de liquidité
Transaction in Own Shares
2025-07-03 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-07-03 French
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Capital/Financing Update
2025-06-26 English
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de compléments alimentaires
Capital/Financing Update
2025-06-26 French
VALBIOTIS SA: Valbiotis announces the success of its 6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Capital/Financing Update
2025-06-26 English
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly €6.9 million, secured by subscription commitments of 75
Capital/Financing Update
2025-06-06 English
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec maintien du DPS d’un montant de 6,9 M€ sécurisée par des engagements à hauteur de 75,0%
Capital/Financing Update
2025-06-06 French
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly 6.9 million, secured by subscription commitments of 75
Capital/Financing Update
2025-06-06 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-06-02 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-06-02 French
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
Regulatory Filings
2025-05-22 English
VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain  sa solution ValbiotisPRO® Cardio-circulation
Regulatory Filings
2025-05-22 French
VALBIOTIS SA: Valbiotis to launch ValbiotisPRO Cardio-circulation on 2 June
Regulatory Filings
2025-05-22 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-05-14 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-05-14 French
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales
Earnings Release Q1 2025
2025-05-06 English
VALBIOTIS SA: Extension du maillage commercial, lancements de produits, montée en puissance des ventes en pharmacies et sur le web : un début d’année en ligne avec le plan de marche
Earnings Release Q1 2025
2025-05-06 French
VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales
Regulatory Filings
2025-05-06 English
VALBIOTIS SA: Compte-rendu de l’Assemblée générale mixte du 18 avril 2025
AGM Information
2025-04-18 French
VALBIOTIS SA: Compte-rendu de lAssemblee generale mixte du 18 avril 2025
AGM Information
2025-04-18 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-04-07 French
VALBIOTIS SA: Valbiotis annonce la tenue de son Assemblée générale mixte des actionnaires le 18 avril 2025
AGM Information
2025-03-31 French
VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships
Regulatory Filings
2025-03-31 English
VALBIOTIS SA: Valbiotis® renforce son ancrage officinal avec deux partenariats stratégiques
Regulatory Filings
2025-03-31 French
VALBIOTIS SA: Valbiotis annonce la tenue de son Assemblee generale mixte des actionnaires le 18 avril 2025
AGM Information
2025-03-31 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-03-19 French
VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis offers a scientifically proven alternative to red yeast rice for cholesterol management
Regulatory Filings
2025-03-18 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-03-18 French
VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management
Regulatory Filings
2025-03-17 English
VALBIOTIS SA: Valbiotis® anticipe l’évolution de la réglementation et propose une alternative scientifiquement prouvée sans levure de riz rouge pour la gestion du cholestérol
Regulatory Filings
2025-03-17 French
VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis offers a scientifically proven alternative to red yeast rice for cholesterol management
Regulatory Filings
2025-03-17 English
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Earnings Release FY 2024
2025-03-04 English
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Earnings Release FY 2024
2025-03-03 English
VALBIOTIS SA: Valbiotis dévoile ses comptes annuels et confirme ses ambitions stratégiques et financières
Earnings Release FY 2024
2025-03-03 French
VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals
Earnings Release FY 2024
2025-03-03 English
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-25 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-24 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-24 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-24 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-18 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Regulatory Filings
2025-02-17 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-17 French
VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2025-02-17 French
VALBIOTIS SA: Valbiotis commercialisera dès le 3 février prochain  sa solution Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques
Regulatory Filings
2025-01-30 French
VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, Valbiotis®PRO Metabolic Health (Totum•63), on February 3rd
Regulatory Filings
2025-01-30 English
VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, ValbiotisPRO Metabolic Health (Totum63), on February 3rd
Regulatory Filings
2025-01-30 English
VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Earnings Release Q4 2024
2025-01-21 English
VALBIOTIS SA: Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030
Earnings Release Q4 2024
2025-01-21 French
VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Regulatory Filings
2025-01-21 English
VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
Earnings Release Q1 2025
2025-01-14 English
VALBIOTIS SA: Valbiotis annonce le large succès de l’étude clinique de phase II/III HEART II sur LIPIDRIVE
Regulatory Filings
2025-01-14 French
VALBIOTIS SA: Valbiotis announces the major success of the phase II/III HEART II clinical study on LIPIDRIVE
Regulatory Filings
2025-01-14 English
VALBIOTIS SA: Bilan semestriel du contrat de liquidité
Transaction in Own Shares
2025-01-08 French
VALBIOTIS SA: Bilan semestriel du contrat de liquidite
Regulatory Filings
2025-01-08 French